UCB SA(UCB.BR)— 技術面狀態
數據截至2026-10-12 — 每個交易日晚間對全部追蹤範圍重新計算。Closelook研究日記,不構成投資建議。
Trades -4.4% vs the 50-day and -15.9% vs the 200-day average, 29.3% below the 52-week high and +2.6% off the 52-week low; a death cross printed 45 sessions ago. Computed from daily closes.
移動平均線狀態
- 相對20日均線-1.6%
- 相對50日均線-4.4%
- 相對200日均線-15.9%
- 52週區間低於52週高點29.3% · 高於52週低點2.6%
- 連續走勢連續2個交易日上漲
- 均線交叉死亡交叉(45個交易日前)
- 50日均線交叉股價向下穿越50日均線(52個交易日前)
- 隨機指標%K 28.1 · %D 23.3(黃金交叉)
相關頁面: UCB.BR圖表與概覽 · 品質與財務體檢 · 訊號看板
FAQ · from the current data · as of 2026-10-12
Quick answers
UCB.BR目前的Closelook訊號是什麼?
Downtrend stack — Trades -4.4% vs the 50-day and -15.9% vs the 200-day average, 29.3% below the 52-week high and +2.6% off the 52-week low; a death cross printed 45 sessions ago. Computed from daily closes.(截至2026-10-12;訊號看板每個交易日晚間對全部追蹤範圍重新計算。研究日記讀數,不構成投資建議。)
UCB.BR目前是否位於50日與200日均線上方?
截至2026-10-12,UCB SA位於50日均線下方(-4.4%),200日均線下方(-15.9%);距20日均線-1.6%。
UCB.BR距52週高點有多遠?
截至2026-10-12,低於52週高點29.3%,高於52週低點2.6%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry